← SynDRA
ANCITABINE
SynDRA canonical compound SYN0025239 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | DNA synthesis inhibitor | RNA synthesis inhibitor |
|---|
Mechanisms of action (all sources)
- DNA synthesis inhibitor
- RNA synthesis inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- PGR
- KDR
- KMT2A
- LMNA
- MAOA
- MTOR
- NFE2L2
- OPRM1
- PDE3A
- PDE4A
- PIN1
- ADORA3
- POLI
- PTGS1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- SMN1
- TBXA2R
- KCNH2
- HTR2B
- HTR1A
- HRH3
- ADRA1A
- ADRA2A
- ALDH1A1
- AR
- ATXN2
- CBX1
- CGA
- CHRM1
- CHRM2
- CYP2C19
- DRD1
- DRD3
- ESR1
- EYA2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- BARD1
- BRCA1
- MDM2
- MDM4
- TP53
Drug classes
- Antimetabolites
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Noxae
Cross-references
Synonyms
- ancytabine
- cyclocytidine
- Ancitabina
- cyclocytidine-hcl
- Cyclocytidine
- 2,2'-Anhydrocytidine
- Ancytabine
- 2,2'-Cyclocytidine
- Anhydrocytidine
- Anhydroara C
- Ancitabine [INN]
- Ancitabinum
- 2,2'-Anhydroarabinosylcytosine
- 2,2'-O-Cyclocytidine
- DO2D32W0VC
- Cyclo-C
- (2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-6-imino-6H-furo(2',3';4,5)oxazolo(3,2-a)pyrimidine-2-methanol
- CHEBI:74838
- NCGC00159322-02
- 2,2'-Anhydro-(beta-D-arabinofuranosyl)cytidine
- (2R,3R,3aS,9aR)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol
- MLS001173324
- Ancitabinum [INN-Latin]
- Ancitabina [INN-Spanish]
- O(sup 2),2'-Cyclocytidine
- CAS-31698-14-3
- CCRIS 2757
- NSC145668
- SMR000538927
- UNII-DO2D32W0VC
- (-)-Cyclocytidine hydrochloride
- OCTD
- 2,2'-anhydro-AraC
- NSC129220
- ANCITABINE [MI]
- O(2,2')-cyclocytidine
- 2,2'-Anhydro-L-cytidine
Look up ANCITABINE in the interactive SynDRA portal →